{"id":"W3092419127","doi":"10.1080/03007995.2020.1835851","title":"Healthcare resource utilization and costs associated with first-line ibrutinib compared to chemoimmunotherapy treatment among Medicare beneficiaries with chronic lymphocytic leukemia","year":2020,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Ibrutinib; Medicine; Chemoimmunotherapy; Medicare Advantage; Chronic lymphocytic leukemia; Internal medicine; Ofatumumab; Pharmacy; Health care; Oncology; Leukemia; Family medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009219978,0.0003583604,0.0007012341,0.0002295118,0.000464125,0.0001064203,0.0002395018,0.0002564767,0.0001277451],"category_scores_gemma":[0.002362947,0.0002384478,0.00004329702,0.001095878,0.0009689482,0.00009776471,0.000221017,0.0007291889,0.00001170071],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.03371283,"about_ca_system_score_gemma":0.02816934,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002149085,"about_ca_topic_score_gemma":0.003903412,"domain_scores_codex":[0.9943916,0.0002829578,0.0004611709,0.0008674791,0.002951571,0.001045219],"domain_scores_gemma":[0.9953578,0.001169598,0.00009587454,0.000394742,0.0005236506,0.002458402],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.02610474,0.0008646254,0.04202009,0.005563387,0.001037513,0.0007110412,0.01270765,0.000325753,0.00007183279,0.0008377956,0.009979692,0.8997759],"study_design_scores_gemma":[0.1748937,0.05356566,0.05832848,0.03626173,0.0001731363,0.0003773935,0.003188614,0.4494333,0.001680738,0.00007319697,0.2205638,0.001460266],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9566903,0.02504984,0.0003707299,0.01506572,0.00007751142,0.002422893,0.00005000657,0.0001513641,0.0001216328],"genre_scores_gemma":[0.9772183,0.02090671,0.0000308472,0.0003316332,0.0004530436,0.000214847,0.000738888,0.00006132518,0.00004440228],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8983156,"threshold_uncertainty_score":0.97734,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1348852793678069,"score_gpt":0.4044661884187354,"score_spread":0.2695809090509285,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}